TE_170
Basic information Differential Expression Stage analysis Survival analysis Correlation analysis| TE family | L2c_3end |
|---|---|
| TE superfamily | L2 |
| TE class | LINE |
| Gene | SDHB |
| Class | Annoated |
| Coding | Non-coding |
| Tumor-specific score | 4.27 |
| Counts of samples | TCGA_tumor:2933; TCGA_normal:136; GTEx:637 |
| TSS | chr1(-):17045247 |
Transcript isoforms
| Transcript_ID | Gene | Class | Coding | ORF | Position |
|---|---|---|---|---|---|
| teRNA_170.1 | SDHB | Annoated | Non-coding | Non-coding | chr1(-):17018938,17018958,17022608,17022730,17023973,17024074,17027749,17027865,17028600,17028736,17033060,17033145,17044761,17044888,17045141,17045248 |
1
GTEx
The proportion of samples in which the TE-initiated transcript was expressed across 46 body sites in the Genotype-Tissue Expression (GTEx) project.
TCGA
The proportion of samples in which the TE-initiated transcript was expressed across 33 cancer types from The Cancer Genome Atlas (TCGA).
GTEx
The expression of TE-initiated transcript across 46 body sites from The Genotype-Tissue Expression (GTEx) project.
